Company news
Lixte Biotechnology Holdings, Inc. news in 2020
Lixte Biotechnology Holdings, Inc.'s news releases, calls and decks from 2020, newest first.
Lixte Biotechnology Holdings, Inc. Announces Closing of Public Offering and Uplisting to Nasdaq
November 30, 2020
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
November 24, 2020
Lixte Biotechnology Holdings, Inc. Announces The Appointment Of Internationally Recognized Clinical Cancer Investigator, James S. Miser MD, As Chief Medical Officer
July 20, 2020